Results of the FINEARTS-HF randomized clinical trial demonstrate that the PREDICT-HFpEF models performed well in terms of calibration and discrimination. Baseline risk did not modify the benefit of finerenone. jamanetwork.com/journals/jam...
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model
This randomized clinical trial evaluated the effectiveness of finerenone in patients with heart failure and mildly reduced ejection fraction or preserved ejection fraction across the spectrum of risk ...
jamanetwork.com